Retrospective Cohort Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2014; 20(47): 17941-17948
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17941
Figure 1
Figure 1 Kaplan-Meier plots showing the cumulative incidence of rebleeding in 6 wk stratified according to (A) risk stigmata of variceal bleeding, (B) obliteration range of percutaneous transhepatic variceal embolization, and (C) hepatic vein pressure gradient. The curves are compared using a log-rank test. PTVE: Percutaneous transhepatic variceal embolization; HVPG: Hepatic vein pressure gradient.
Figure 2
Figure 2 Kaplan-Meier plots showing the cumulative incidence of death in 6 wk stratified according to model for end-stage liver disease (A) and hepatic vein pressure gradient (B). The curves are compared using a log-rank test. MELD: Model for end-stage liver disease; HVPG: Hepatic vein pressure gradient.